Market Overview:
The global sleep disorder therapeutics market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of sleep disorders, rising awareness about available treatments, and growing demand for better-quality sleep. Based on type, the global sleep disorder therapeutics market is segmented into insomnia, excessive sleep, and disturbed sleep. Insomnia is estimated to account for the largest share of the global market in 2018 owing to its high prevalence rate. By application, hospital pharmacies are estimated to account for the largest share of the global market in 2018 followed by online pharmacies and retail pharmacies. Geographically, North America is estimated to account for the largest share of the global market in 2018 followed by Europe and Asia Pacific.
Product Definition:
Sleep disorder therapeutics is the branch of medicine that deals with the diagnosis and treatment of sleep disorders. Sleep disorders are a group of conditions that cause difficulty falling or staying asleep, or lead to excessive daytime sleepiness. They can affect people of any age, but are most common in adults. Some common sleep disorders include insomnia, narcolepsy, and obstructive sleep apnea.
Sleep disorder therapeutics is important because it can help people who have difficulty sleeping to get the rest they need to function properly during the day. It can also improve quality of life for those with chronic sleep problems.
Insomnia:
Insomnia is a sleep disorder wherein there is an inability to fall asleep or stay asleep. It can be characterized by restlessness, anxiety, and difficulty in relaxing. Insomnia can lead to health risks such as high blood pressure, heart disease, depression, substance abuse and accidents. According to the National Sleep Foundation's (NSF) survey results published in 2017; around 40-50% of U.
Excessive Sleep:
Excessive sleep is a condition where a person has too much sleep and it may lead to various disorders. It can be due to several reasons such as shift work, illness, or another medical condition that causes insomnia. The other factor that leads to excessive sleep is the use of certain medications like benzodiazepines and sedatives which are used for anxiety and sleeping problems respectively.
Application Insights:
Based on application, the market is segmented into hospital pharmacies, online pharmacies and retail pharmacies. The hospital pharmacy segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as a high prevalence of chronic diseases that require long-term medication management and increasing healthcare costs. According to a study published by NCBI, it was estimated that around 70% of all medications are prescribed in outpatient settings and 30% are given in hospitals or clinics. Thus, an increase in the number of patients visiting hospitals for treatment drives demand for sleep disorder therapeutics at a higher rate than other segments due to its high usage rates among other conditions such as anxiety disorders & depression disorders which also need continuous medication management over a longer period of time during treatment phases.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of sleep disorders, rising awareness about these disorders, and availability of effective treatment methods in this region. Moreover, presence of key players such as Pfizer Inc.; sanofi; Allergan PLC; and Merck & Co., Inc.; will also help North America maintain its dominance during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to growing geriatric population coupled with lifestyle changes such as shift work or travel for long durations that result in insomnia or excessive sleeping disorder patients base in this region. In addition, increasing disposable income levels are also expected favorably impact regional market growth over the next eight years (2030). However, high incidence rate of sleep-related disorders coupled with low awareness about these conditions may hinder Asia Pacific’s growth at a certain level.
Growth Factors:
- Increasing prevalence of sleep disorders: The global prevalence of sleep disorders is increasing due to various factors such as changing lifestyle, growing stress levels, and increasing use of electronic gadgets. This is expected to drive the demand for Sleep Disorder Therapeutics products in the coming years.
- Rising awareness about sleep disorders: There is a growing awareness among people about the importance of good quality sleep and its impact on overall health and well-being. This is likely to boost the demand for Sleep Disorder Therapeutics products in the near future.
- Technological advancements in Sleep Disorder Therapeutics products: The technological advancements in Sleep Disorder Therapeutics products are helping to improve their efficacy and safety profile, which is resulting in an increase in their adoption rate worldwide. This will further fuel the growth of this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sleep Disorder Therapeutics Market Research Report
By Type
Insomnia, Excessive Sleep, Disturbed Sleep
By Application
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
By Companies
Sanofi, Sunovion Pharmaceuticals, Takeda Pharmaceutical, Somaxon Pharmaceuticals, Vanda Pharmaceuticals, Eli Lilly, GSK, Neurim Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Sleep Disorder Therapeutics Market Report Segments:
The global Sleep Disorder Therapeutics market is segmented on the basis of:
Types
Insomnia, Excessive Sleep, Disturbed Sleep
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Sunovion Pharmaceuticals
- Takeda Pharmaceutical
- Somaxon Pharmaceuticals
- Vanda Pharmaceuticals
- Eli Lilly
- GSK
- Neurim Pharmaceuticals
Highlights of The Sleep Disorder Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Insomnia
- Excessive Sleep
- Disturbed Sleep
- By Application:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sleep Disorder Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sleep disorder therapeutics is a sub-discipline of sleep medicine that deals with the treatment of sleep disorders. Sleep disorder therapeutics may include medications, devices, and other treatments used to treat conditions such as narcolepsy, obstructive sleep apnea (OSA), restless leg syndrome (RLS), and insomnia.
Some of the key players operating in the sleep disorder therapeutics market are Sanofi, Sunovion Pharmaceuticals, Takeda Pharmaceutical, Somaxon Pharmaceuticals, Vanda Pharmaceuticals, Eli Lilly, GSK, Neurim Pharmaceuticals.
The sleep disorder therapeutics market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sleep Disorder Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sleep Disorder Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sleep Disorder Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sleep Disorder Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sleep Disorder Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Sleep Disorder Therapeutics Market Size and Y-o-Y Growth
4.5.2 Sleep Disorder Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Insomnia
5.2.2 Excessive Sleep
5.2.3 Disturbed Sleep
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Online Pharmacies
6.2.3 Retail Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sleep Disorder Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sleep Disorder Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Insomnia
9.6.2 Excessive Sleep
9.6.3 Disturbed Sleep
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Online Pharmacies
9.10.3 Retail Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Insomnia
10.6.2 Excessive Sleep
10.6.3 Disturbed Sleep
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Online Pharmacies
10.10.3 Retail Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Insomnia
11.6.2 Excessive Sleep
11.6.3 Disturbed Sleep
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Online Pharmacies
11.10.3 Retail Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Insomnia
12.6.2 Excessive Sleep
12.6.3 Disturbed Sleep
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Online Pharmacies
12.10.3 Retail Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Insomnia
13.6.2 Excessive Sleep
13.6.3 Disturbed Sleep
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Online Pharmacies
13.10.3 Retail Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sleep Disorder Therapeutics Market: Competitive Dashboard
14.2 Global Sleep Disorder Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Sunovion Pharmaceuticals
14.3.3 Takeda Pharmaceutical
14.3.4 Somaxon Pharmaceuticals
14.3.5 Vanda Pharmaceuticals
14.3.6 Eli Lilly
14.3.7 GSK
14.3.8 Neurim Pharmaceuticals
